text.skipToContent text.skipToNavigation

Sartorius Stedim Biotech Investor Relations

First-Quarter 2017 Results

Dr. Joachim Kreuzburg, CEO, will discuss the company's first-quarter 2017 results with analysts and investors on Monday, April 24, 2017, in a teleconference. To register please click here.

Alternatively, you can dial into the teleconference, without registering, at: +49 (0) 69 566 03 6000

Annual Report 2016

Facts & Figures

Download a brief overview of Sartorius Stedim Biotech and its current economic development.

Sartorius Stedim Biotech Share (DIM)